The Federal Trade Commission (FTC) and the Justice Department's Antitrust Division, in collaboration with the Department of Commerce and the Department of Health and Human Services, are set to host a listening session on July 24, 2025. This event is part of a series aimed at exploring strategies to reduce prescription drug prices through enhanced competition.
The upcoming session will focus on formulary and benefit practices as well as regulatory abuse that affects drug competition. It will feature insights from practitioners and scholars. While attendance in person is by invitation only, the event will be available for streaming online. The public is encouraged to submit questions via the internet.
The FTC emphasizes its role in promoting competition and protecting consumers. The organization also warns against scams involving demands for money or promises of prizes. More information about consumer benefits from competition can be found on their website, along with resources for filing antitrust complaints.
For updates, individuals are invited to follow the FTC on social media, subscribe to press releases, and read their blog.
